Patients across Mexico diagnosed with Retinitis Pigmentosa typically find that conventional treatment remains centered on low-vision aids, closely supervised vitamin A supplementation, and addressing secondary issues such as cataract. As no widely accepted cure exists yet in mainstream ophthalmology, many patients look outside their home country for further options. India has become a leading choice for **Retinitis Pigmentosa treatment for patients from Mexico**, though it’s important to understand that a complete cure for this inherited condition remains a complex, ongoing pursuit within global medicine.
Within a wider Retinitis Pigmentosa treatment strategy, stem cell-based intervention has drawn growing clinical attention. Since RP progressively affects the retina’s rod and cone photoreceptor cells, approaches that aim to support the surviving retinal cell base are viewed as a worthwhile area for patients to explore, serving alongside — not in place of — standard low-vision management.
As part of a structured Retinitis Pigmentosa treatment plan, Mesenchymal stem cell injections given through the Retro-bulbar route have become a frequently chosen method, usually spread across one or two sessions. This approach has built an encouraging record supporting retinal cell regeneration among patients with progressive, inherited retinal disease, extending its relevance to photoreceptor cells, the retinal pigment epithelium, and optic nerve tissue.
Patients from Mexico researching Retinitis Pigmentosa treatment are welcome to reach out to the Eye Stem Cell Center, backed by more than 12 years of focused work assessing and treating inherited retinal conditions. Our team carefully reviews each patient’s retinal reports before recommending any next step.
Eye Stem Cell Center is one of the most trusted providers of Retinitis Pigmentosa treatment in Mexico.

